# FDA 483 - RNA Bio/Pharma Inc - April 11, 2025

Source: https://www.keypedia.com/records/483/rna-biopharma-inc/0a5cb18c-2d1b-4b72-91a9-fb72608195cc

> FDA 483 for RNA Bio/Pharma Inc on April 11, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: RNA Bio/Pharma Inc
- Inspection Date: 2025-04-11
- Product Type: drugs
- Office Name: Seattle District Office
- Summary: RNA Bio/Pharma Inc in Chelan, WA, was inspected and received a Form 483 with four repeat observations. The inspection revealed significant deficiencies in quality control, component testing, water system validation, and stability assessment for their homeopathic drug products. These issues indicate a lack of fundamental controls necessary for drug manufacturing.

## Related Officers

- [Bryan L. Mcguckin](https://www.keypedia.com/people/bryan-l-mcguckin/33eaa16d-a642-4945-81f3-5d9ac180c2db)

Company: https://www.keypedia.com/companies/rna-biopharma-inc/eacb25ab-7668-444a-be5f-52117a9e5b63

Office: https://www.keypedia.com/offices/seattle-district-office/9305837f-0738-4075-b444-a55e7a2b8913